Pharmacokinetics and tissue distribution of apigenin niosomes

Chinese Pharmaceutical Journal

Volumn 44, Issue 13, 2009, Pages 1009-1013

  Liu, Dan ^a   Hu, Hai Yang ^a   Chen, Da Wei ^a   Liu, Ren ^a   Zhao, Xiu Li ^a   Qiao, Ming Xi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Apigenin; Niosomes; Nonionic surfactant; Pharmacokinetics; Tissue dirtubution

Indexed keywords

APIGENIN; NIOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TISSUE LEVEL; HEART; IN VIVO STUDY; KIDNEY; MOUSE; NONHUMAN; PARTICLE SIZE; RAT; TISSUE DISTRIBUTION;

EID: 68449098913     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. SUN B, QU W Q, ZHANG X L. The research progression in pharmacological action of apigenin [J]. J Chin Med Mater, 2004, 27(7):531-534.
2. CHEN D I, DANIEL K D, CHEN M S, et al. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cell[J]. Biochem Pharmacol, 2005, 69 (10) : 1421-1432.
3. TAJDAR HUSAIN KHAN, SARWAT SULTANA. Apigenin induces apoptosis in Hep G2 cells:Possible role of TNF-α and IFN-γ[J]. Toxicol, 2006, 217 (2-3): 206-212.
4. ZHANG J A, ANYARAMBHATLA G, MA L, et al. Development and characterization of a novel Cremophorw EL free liposome-based paclitaxel (LEP-ETU) formulation[J]. Eur J Pharm Biopharm, 2005, 59 (1) : 177-187.
5. SHI X G, ZHONG D F, ZHANG Y F, et al. Determination of silybin in the rat plasma by RP-HPLC [J]. J Shenyang Pharm Univ, 2001, 18(2): 113-115.
6. GUPTA P K, HUNG C T. Quantitative evaluation of targeted drug delivery systems[J]. Int J Pharm, 1989, 56 (2): 217-226. (Pubitemid 20004824)
7. WANG S N, DENG Y H, XU H, et al. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin[J]. Eur J Pharm Biopharm, 2006, 62 (1): 32-38.
8. ARUNOTHAYANUN P, BERNARD M S, CRAIG D Q M. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether [J]. Int J Pharm, 2000, 201 (1): 7-14.
9. ARANYA MANOSROI, PAVEENA WONGTRAKUL, JIRADEJ MANOSROI, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol [J]. Colloids Surf B Biointerfaces, 2003, 30 (1-2): 129-138.
10. XU C L, YAO H Y. Interaction between polyoxyethylene sorbitol fatty acid esters and liposome membrane [J]. Fine Chem, 2004, 21(12): 897-902.
11. ZHOU W, WENG J Y, CHENG W Z, et al. Tissue distribution of paclitaxel fiposome in rats[J]. Chin Pharm J, 2005, 40(18): 1402-1405.
12. SONG X D, WANG X J, DU X, et al. Preparation of p-elemene liposomes and their tissue distribution in rats[J]. Chin J New Drugs Clin Rem, 2007, 26(10): 733-736.
13. MARIA MANCONI, CHIARA SINICO, DONATELLA VALENTI, et al. Niosomes as carriers for tretinoin. I. Preparation and properties[J]. Int J Pharm, 2002, 234(1-2): 237-248.
14. VYAS S P, SINGH R P, SANYOG JAIN, et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B[J]. Int J Pharm, 2005,296(1-2): 80-86.
15. YOSHIOKA T, STENBERG B, JLORENCE A T .Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span20, 40, 60 and 80) and a sorbitan triester (span 85) [J]. Int J Pharm, 1994, 105 (1): 1-6.
16. ZHANG X B, XIE J Q, HOU X P. Effect of surfactants on the in vitro and in vivo properties of amphotericin B liposome [J]. Acta Pharm Sin(P), 2003, 38(6): 471-474.
17. PAOLO BLASI , STEFANO GIOVAGNOLI , AURÉLIE SCHOUBBEN. Solid lipid nanoparticles for targeted brain drug delivery[J]. Adv Drug Deliv Rev, 2007, 59(6): 454-477. (Pubitemid 47259226)